-
1
-
-
0031947592
-
Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
-
Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-69.
-
(1998)
Am J Pathol
, vol.152
, pp. 1259-1269
-
-
Kindblom, L.G.1
Remotti, H.E.2
Aldenborg, F.3
Meis-Kindblom, J.M.4
-
2
-
-
84965085738
-
Bizarre smooth muscle tumors of the stomach
-
Stout AP. Bizarre smooth muscle tumors of the stomach. Cancer 1962;15:400-9.
-
(1962)
Cancer
, vol.15
, pp. 400-409
-
-
Stout, A.P.1
-
3
-
-
0021344548
-
Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma): Light and electron microscopic study confirming the origin of the neoplasm
-
Herrera GA, Demoraes HP, Grizzle WE, Han SG. Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma): Light and electron microscopic study confirming the origin of the neoplasm. Dig Dis Sci 1984;29:275-84.
-
(1984)
Dig Dis Sci
, vol.29
, pp. 275-284
-
-
Herrera, G.A.1
Demoraes, H.P.2
Grizzle, W.E.3
Han, S.G.4
-
4
-
-
0024359742
-
Gastrointestinal autonomic nerve tumors. 'Plexosarcomas'
-
Herrera GA, Cerezo L, Jones JE, et al. Gastrointestinal autonomic nerve tumors. 'Plexosarcomas'. Arch Pathol Lab Med 1989;113:846-53.
-
(1989)
Arch Pathol Lab Med
, vol.113
, pp. 846-853
-
-
Herrera, G.A.1
Cerezo, L.2
Jones, J.E.3
-
5
-
-
0031857113
-
CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34
-
Sarlomo-Rikala M, Kovatich AJ. Barusevicius A, Miettinen M. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 1998;11:728-34.
-
(1998)
Mod Pathol
, vol.11
, pp. 728-734
-
-
Sarlomo-Rikala, M.1
Kovatich, A.J.2
Barusevicius, A.3
Miettinen, M.4
-
6
-
-
0033984319
-
Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival
-
DeMatteo RP, Lewis JL, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231:51-8.
-
(2000)
Ann Surg
, vol.231
, pp. 51-58
-
-
DeMatteo, R.P.1
Lewis, J.L.2
Leung, D.3
Mudan, S.S.4
Woodruff, J.M.5
Brennan, M.F.6
-
7
-
-
0018742458
-
The triad of gastric epithelioid leiomyosarcoma, functioning extra-adrenal paraganglioma, and pulmonary chondroma
-
Carney JA. The triad of gastric epithelioid leiomyosarcoma, functioning extra-adrenal paraganglioma, and pulmonary chondroma. Cancer 1979;43:374-82.
-
(1979)
Cancer
, vol.43
, pp. 374-382
-
-
Carney, J.A.1
-
8
-
-
0032884854
-
Gastrointestinal stromal tumors: Recent advances in understanding of their biology
-
Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol 1999;30:1213-20.
-
(1999)
Hum Pathol
, vol.30
, pp. 1213-1220
-
-
Miettinen, M.1
Sarlomo-Rikala, M.2
Lasota, J.3
-
9
-
-
0026598711
-
Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging
-
Ng EH, Pollock RE, Munsell MF, Atkinson EN, Romsdahl MM. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg 1992;215:68-77.
-
(1992)
Ann Surg
, vol.215
, pp. 68-77
-
-
Ng, E.H.1
Pollock, R.E.2
Munsell, M.F.3
Atkinson, E.N.4
Romsdahl, M.M.5
-
10
-
-
0035122393
-
Malignant gastrointestinal stromal tumors of the small intestine: A review of 50 cases from a prospective database
-
Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small intestine: A review of 50 cases from a prospective database. Ann Surg Oncol 2001;8:50-9.
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 50-59
-
-
Crosby, J.A.1
Catton, C.N.2
Davis, A.3
-
11
-
-
0035086040
-
Adjuvant radiotherapy for gastrointestinal stromal tumor of the rectum
-
Pollock J, Morgan D, Denobile J, Williams J. Adjuvant radiotherapy for gastrointestinal stromal tumor of the rectum. Dig Dis Sci 2001;46:268-72.
-
(2001)
Dig Dis Sci
, vol.46
, pp. 268-272
-
-
Pollock, J.1
Morgan, D.2
Denobile, J.3
Williams, J.4
-
12
-
-
0026543276
-
Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas
-
Ng EH, Pollock RE, Romsdahl MM. Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 1992;69:1334-41.
-
(1992)
Cancer
, vol.69
, pp. 1334-1341
-
-
Ng, E.H.1
Pollock, R.E.2
Romsdahl, M.M.3
-
13
-
-
0000084433
-
Contrast of response to D-MAP + sargramostim between patients with advance malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas
-
Edmondson J, Marks R, Buckner J, Mahoney M. Contrast of response to D-MAP + sargramostim between patients with advance malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas. Proc Am Soc Clin Oncol 1999;18:541.
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
, pp. 541
-
-
Edmondson, J.1
Marks, R.2
Buckner, J.3
Mahoney, M.4
-
14
-
-
0000014589
-
Clinical and pathological characteristics of gastrointestinal stromal tumors
-
Goss G, Merriam P, Manola J, Singer S, Fletcher C, Demetri G. Clinical and pathological characteristics of gastrointestinal stromal tumors. Proc Am Soc Clin Oncol 2000;19:2203.
-
(2000)
Proc Am Soc Clin Oncol
, vol.19
, pp. 2203
-
-
Goss, G.1
Merriam, P.2
Manola, J.3
Singer, S.4
Fletcher, C.5
Demetri, G.6
-
15
-
-
0034666327
-
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: Differences in clinical outcome and expression of multidrug resistance proteins
-
Plaat BE. Hollema H, Molenaar WM, et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: Differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol 2000;18:3211-20.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3211-3220
-
-
Plaat, B.E.1
Hollema, H.2
Molenaar, W.M.3
-
16
-
-
0033105659
-
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment
-
Berthet B, Sugarbaker TA, Chang D, Sugarbaker PH. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 1999;35:413-9.
-
(1999)
Eur J Cancer
, vol.35
, pp. 413-419
-
-
Berthet, B.1
Sugarbaker, T.A.2
Chang, D.3
Sugarbaker, P.H.4
-
17
-
-
0032701962
-
Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas
-
Eilber FC, Rosen G, Forscher C, Nelson S, Dorey F, Eilber FR. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol 1999;6:645-50,
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 645-650
-
-
Eilber, F.C.1
Rosen, G.2
Forscher, C.3
Nelson, S.4
Dorey, F.5
Eilber, F.R.6
-
18
-
-
0033693772
-
Recurrent gastrointestinal stromal sarcomas
-
Eilber FC, Rosen G, Forscher C, Nelson SD, Dorey F, Eilber FR. Recurrent gastrointestinal stromal sarcomas. Surg Oncol 2000;9:71-5.
-
(2000)
Surg Oncol
, vol.9
, pp. 71-75
-
-
Eilber, F.C.1
Rosen, G.2
Forscher, C.3
Nelson, S.D.4
Dorey, F.5
Eilber, F.R.6
-
19
-
-
0025017802
-
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer
-
Markman M, George M, Hakes T, et al. Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer. J Clin Oncol 1990;8:146-50.
-
(1990)
J Clin Oncol
, vol.8
, pp. 146-150
-
-
Markman, M.1
George, M.2
Hakes, T.3
-
20
-
-
0034794797
-
Results of hepatic resection for sarcoma metastatic to liver
-
DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001;234:540-8.
-
(2001)
Ann Surg
, vol.234
, pp. 540-548
-
-
DeMatteo, R.P.1
Shah, A.2
Fong, Y.3
Jarnagin, W.R.4
Blumgart, L.H.5
Brennan, M.F.6
-
21
-
-
0342369352
-
Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period
-
Lang H, Nussbaum KT, Kaudel P, Fruhauf N, Flemming P, Raab R. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000;231:500-5.
-
(2000)
Ann Surg
, vol.231
, pp. 500-505
-
-
Lang, H.1
Nussbaum, K.T.2
Kaudel, P.3
Fruhauf, N.4
Flemming, P.5
Raab, R.6
-
22
-
-
0035117662
-
Sarcomas metastatic to the liver: Response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization
-
Rajan DK, Soulen MC, Clark TW, et al. Sarcomas metastatic to the liver: Response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. J Vasc Interv Radiol 2001;12:187-93.
-
(2001)
J Vasc Interv Radiol
, vol.12
, pp. 187-193
-
-
Rajan, D.K.1
Soulen, M.C.2
Clark, T.W.3
-
23
-
-
0028958778
-
Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine
-
Mavligit GM, Zukwiski AA, Ellis LM, Chuang VP, Wallace S, Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer 1995;75:2083-8.
-
(1995)
Cancer
, vol.75
, pp. 2083-2088
-
-
Mavligit, G.M.1
Zukwiski, A.A.2
Ellis, L.M.3
Chuang, V.P.4
Wallace, S.5
-
24
-
-
2742529418
-
Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand
-
Yarden Y, Kuang WJ, Yang-Feng T, et al. Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-51.
-
(1987)
EMBO J
, vol.6
, pp. 3341-3351
-
-
Yarden, Y.1
Kuang, W.J.2
Yang-Feng, T.3
-
25
-
-
0022626874
-
A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family
-
Besmer P, Murphy JE, George PC, et al. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 1986;320:415-21.
-
(1986)
Nature
, vol.320
, pp. 415-421
-
-
Besmer, P.1
Murphy, J.E.2
George, P.C.3
-
26
-
-
15644363454
-
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
-
Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577-80.
-
(1998)
Science
, vol.279
, pp. 577-580
-
-
Hirota, S.1
Isozaki, K.2
Moriyama, Y.3
-
27
-
-
0033883060
-
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
-
Lux ML, Rubin BP, Biase TL, et al. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 2000;156:791-5.
-
(2000)
Am J Pathol
, vol.156
, pp. 791-795
-
-
Lux, M.L.1
Rubin, B.P.2
Biase, T.L.3
-
28
-
-
0000244046
-
Evaluation of the molecularly targeted therapy STI 571 in patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
-
Blanke CD, von Mehren M, Joensuu H, et al. Evaluation of the molecularly targeted therapy STI 571 in patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. Proc Am Soc Clin Oncol 2001;20:2. Available at: http://virtualmeeting. asco.org/vm2001/interest_areas/special_sessions/plenary.htm. Accessed: September 3, 2002.
-
(2001)
Proc Am Soc Clin Oncol
-
-
Blanke, C.D.1
Von Mehren, M.2
Joensuu, H.3
-
29
-
-
0031848146
-
Familial gastrointestinal stromal turnouts with germline mutation of the KIT gene
-
Nishida T. Familial gastrointestinal stromal turnouts with germline mutation of the KIT gene. Nat Genet 1998;19:323-4.
-
(1998)
Nat Genet
, vol.19
, pp. 323-324
-
-
Nishida, T.1
-
30
-
-
0034993741
-
Classes of c-KIT activating mutations: Proposed mechanisms of action and implications for disease classification and therapy
-
Longley BJ, Reguera MJ, Ma Y. Classes of c-KIT activating mutations: Proposed mechanisms of action and implications for disease classification and therapy. Leuk Res 2001;25:571-6.
-
(2001)
Leuk Res
, vol.25
, pp. 571-576
-
-
Longley, B.J.1
Reguera, M.J.2
Ma, Y.3
-
31
-
-
0032953812
-
Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
-
Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999;154:53-60.
-
(1999)
Am J Pathol
, vol.154
, pp. 53-60
-
-
Lasota, J.1
Jasinski, M.2
Sarlomo-Rikala, M.3
Miettinen, M.4
-
32
-
-
0033199890
-
Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
-
Taniguchi M, Nishida T, Hirota S, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999;59: 4297-300.
-
(1999)
Cancer Res
, vol.59
, pp. 4297-4300
-
-
Taniguchi, M.1
Nishida, T.2
Hirota, S.3
-
33
-
-
0034660868
-
DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance
-
El Rifai W, Sarlomo-Rikala M, Andersson LC, Knuutila S, Miettinen M. DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance. Cancer Res 2000;60:3899-903.
-
(2000)
Cancer Res
, vol.60
, pp. 3899-3903
-
-
El Rifai, W.1
Sarlomo-Rikala, M.2
Andersson, L.C.3
Knuutila, S.4
Miettinen, M.5
-
34
-
-
0032408616
-
KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
-
Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary TJ. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 1998;78:1633-6.
-
(1998)
Lab Invest
, vol.78
, pp. 1633-1636
-
-
Ernst, S.I.1
Hubbs, A.E.2
Przygodzki, R.M.3
Emory, T.S.4
Sobin, L.H.5
O'Leary, T.J.6
-
35
-
-
0029947186
-
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
-
Druker BJ. Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996;2:561-6.
-
(1996)
Nat Med
, vol.2
, pp. 561-566
-
-
Druker, B.J.1
Tamura, S.2
Buchdunger, E.3
-
36
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
-
Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-7.
-
(2001)
N Engl J Med
, vol.344
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
-
37
-
-
0035810142
-
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
-
Druker BJ, Sawyers CL, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001;344:1038-42.
-
(2001)
N Engl J Med
, vol.344
, pp. 1038-1042
-
-
Druker, B.J.1
Sawyers, C.L.2
Kantarjian, H.3
-
38
-
-
0030031766
-
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
-
Buchdunger E, Zimmermann J, Mett H, et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 1996;56:100-4.
-
(1996)
Cancer Res
, vol.56
, pp. 100-104
-
-
Buchdunger, E.1
Zimmermann, J.2
Mett, H.3
-
39
-
-
0029947186
-
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
-
Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells, Nat Med 1996;2:561-6.
-
(1996)
Nat Med
, vol.2
, pp. 561-566
-
-
Druker, B.J.1
Tamura, S.2
Buchdunger, E.3
-
40
-
-
0033816156
-
Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors
-
Buchdunger E, Cioffi CL, Law N, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 2000;295:139-45.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 139-145
-
-
Buchdunger, E.1
Cioffi, C.L.2
Law, N.3
-
41
-
-
0034254249
-
Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor
-
Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ. Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor. Blood 2000;96:925-32.
-
(2000)
Blood
, vol.96
, pp. 925-932
-
-
Heinrich, M.C.1
Griffith, D.J.2
Druker, B.J.3
Wait, C.L.4
Ott, K.A.5
Zigler, A.J.6
-
42
-
-
0035899418
-
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications
-
Tuveson DA, Willis NA, Jacks T, et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications. Oncogene 2001:20:5054-8.
-
(2001)
Oncogene
, vol.20
, pp. 5054-5058
-
-
Tuveson, D.A.1
Willis, N.A.2
Jacks, T.3
-
43
-
-
0035810148
-
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
-
Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-6.
-
(2001)
N Engl J Med
, vol.344
, pp. 1052-1056
-
-
Joensuu, H.1
Roberts, P.J.2
Sarlomo-Rikala, M.3
-
44
-
-
0002499759
-
STI 571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase I study
-
Van Oosterom AT, Judson I, Verweij J, et al. STI 571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase I study. Proc Am Soc Clin Oncol 2001;20:2.
-
(2001)
Proc Am Soc Clin Oncol
, vol.20
, pp. 2
-
-
Van Oosterom, A.T.1
Judson, I.2
Verweij, J.3
-
45
-
-
0035960428
-
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: A phase I study
-
Van Oosterom AT, Judson I, Verweij J, et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumors: A phase I study. Lancet 2001;358:1421-3.
-
(2001)
Lancet
, vol.358
, pp. 1421-1423
-
-
Van Oosterom, A.T.1
Judson, I.2
Verweij, J.3
-
46
-
-
0011092772
-
-
American College of Surgeons Oncology Group. http://www. acosog.org. 2002.
-
(2002)
-
-
-
47
-
-
0035800507
-
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
-
Gorre ME, Mohammed M, Ellwood K, et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001;293:876-80.
-
(2001)
Science
, vol.293
, pp. 876-880
-
-
Gorre, M.E.1
Mohammed, M.2
Ellwood, K.3
-
48
-
-
0034161460
-
Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification
-
le Coutre P, Tassi E, Varella-Garcia M, et al, Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood 2000;95:1758-66.
-
(2000)
Blood
, vol.95
, pp. 1758-1766
-
-
Le Coutre, P.1
Tassi, E.2
Varella-Garcia, M.3
-
49
-
-
0034254368
-
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance
-
Mahon FX, Deininger MW, Schultheis B, et al. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance. Blood 2000;96:1070-9.
-
(2000)
Blood
, vol.96
, pp. 1070-1079
-
-
Mahon, F.X.1
Deininger, M.W.2
Schultheis, B.3
-
50
-
-
0034210577
-
Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines
-
Weisberg E, Griffin JD. Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL-transformed hematopoietic cell lines. Blood 2000;95:3498-505.
-
(2000)
Blood
, vol.95
, pp. 3498-3505
-
-
Weisberg, E.1
Griffin, J.D.2
-
51
-
-
0036467568
-
Rational therapeutic intervention in cancer: Kinases as drug targets
-
Sawyers CL. Rational therapeutic intervention in cancer: Kinases as drug targets. Curr Opin Genet Dev 2002;12:111-5.
-
(2002)
Curr Opin Genet Dev
, vol.12
, pp. 111-115
-
-
Sawyers, C.L.1
|